Massivemarkets

CPHI

China Pharma Holdings, Inc.

NYSE American · usd

$0.6586-0.02 (-2.67%)
As of 4:10:00 PM EDT on Oct 23, 2026 · 15-minute delayed

China Pharma Holdings, Inc. (CPHI) trades at $0.6586 (-2.67%) as of 4:10:00 PM EDT on Oct 23, 2026, -10.99% over the past month. Market cap is $29.11M, with 1.0 days to cover in short interest.

Stock performance

How China Pharma Holdings, Inc. (CPHI) stock has performed from one day to one year, with its 52-week range.

-4.68%
-$0.03 over 1D
$0.62$0.64$0.66$0.674:05 AM9:45 AM11:20 AM12:55 PM3:55 PM$0.65
1D
-2.67%
1W
-7.23%
1M
-10.99%
YTD
-45.57%
1Y
-63.73%
52-wk range
$0.38 – $19.19

Key statistics

Today's trading snapshot for CPHI: day range, open, previous close, volume and market cap.

Day range
$0.63 – $0.68
Open
$0.67
Prev close
$0.68
Volume
164.19K
Market cap
$29.11M
Shares out
43.02M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for China Pharma Holdings, Inc.: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
7.47
P/B
0.81
P/FCF
—
ROE
-12.4%
ROA
-10.0%
Debt/Equity
0.10
Div yield
0.00%

As of Oct 22, 2026

8-K filings

Material corporate events China Pharma Holdings, Inc. has disclosed to the SEC on Form 8-K.

  • Equity activityJul 22, 2026

    the Company agreed to issue and the Investor agreed to purchase, in a registered direct offering, an aggregate of 2,500,000 shares of common stock of the Company, par value $0.001 per share at a purchase price of $2.00 per share for aggregate gross proceeds to the Company of $5,000,000

  • Deal agreementsMar 3, 2026

    On February 26, 2026, Hainan Helpson Medical & Biotechnology Co., Ltd entered into a Technology Transfer Agreement with Xiaoyan Zhang. Pursuant to the Agreement, the Transferor will transfer the ownership of the Invention Patent to Helpson. The Transferor or its designated third party shall provide relevant technical services, which include but are not limited to product research and development, writing of registration materials, registration application and other technical services.

  • Deal agreementsFeb 10, 2026

    Hainan Helpson Medical & Biotechnology Co., Ltd entered into a Technology Transfer Agreement with Xiaoyun Chen. The Transferor owns an invention patent of an Topiroxostat Nanoemulsion and Method for Its Preparation. Pursuant to the Agreement, the Transferor will transfer the ownership of the Invention Patent to Helpson.

  • Governance documentsJan 6, 2026

    An amendment to the Company's Articles of Incorporation to effect a reverse stock split, as needed at a ratio up to 1:20, such that every holder of common stock, par value $0.001 per share, of the Company, shall receive one share of common stock for pro rata twenty shares of common stock held was approved and adopted.

  • Deal agreementsDec 23, 2025

    On December 22, 2025, Hainan Helpson Medical & Biotechnology Co., Ltd entered into a Technology Transfer Agreement with Juan Zhang. The Transferor owns an invention patent of an Ipragliflozin tablets and Method for Its Preparation. Pursuant to the Agreement, the Transferor will transfer the ownership of the Invention Patent to Helpson.

Dividend history and stock splits

China Pharma Holdings, Inc.'s recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-10Apr 15, 2025
  • 1-for-5Mar 6, 2024
  • 1-for-10Mar 6, 2023

CPHI short interest

How heavily CPHI is shorted: shares short, days to cover and average daily volume.

Days to cover
1.0
Short interest
61.86K
Avg volume
343.97K

As of · reported to FINRA twice monthly.

CPHI news

The latest news and headlines about China Pharma Holdings, Inc. (CPHI).

Frequently asked questions

What is the China Pharma Holdings, Inc. (CPHI) stock price today?

China Pharma Holdings, Inc. (CPHI) is trading at $0.6586 (-2.67% on the day) as of 4:10:00 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is China Pharma Holdings, Inc.?

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in…

What is the short interest in CPHI?

As of Sep 30, 2026, CPHI has 61.86K shares short and 1.0 days to cover.

What exchange is CPHI listed on?

China Pharma Holdings, Inc. (CPHI) trades on NYSE American in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of CPHI with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CPHI analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Want the most up-to-date, real-time data? Connect to the Massive API and MCP server — the source behind every number on this page — covering stocks, options, indices, currencies and futures. Docs: https://massive.com/docs/rest. Get a free API key.

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.